Scholars International Webinar on

Advances in Drug Discovery and Development

THEME: "Recent Advances in Drug Discovery and Development "

img2 28-30 Mar 2022
img2 Online | Virtual
Andrés Ursa

Andrés Ursa

Instituto de Medicina Integrativa, Spain

Title: Importance of the gut microbiota in the drug development process


Biography

Andrés J. Ursa Herguedas is the Director of the Naturist Clinic and Institute of Integrative Medicine in Valladolid. Teaching official of the Junta de Castilla y León. Care, teaching and research activity. Graduated in Medicine and Surgery from the University of Valladolid in 1983. Rotating services in Gastroenterology, Pulmonology, Traumatology, Obstetrics and Gynecology and Rehabilitation at the Hospital Clínico Universitario de Valladolid. Internal medicine at the Dr. Villacián de Valladolid Assistance Center (former Psychiatric Hospital. Military service with performance in transmissions (for being an electronics technician) and as a doctor in Villanubla (Valladolid). Higher Technician in Acupuncture (1983-85). Naturist Clinicin 1985, which I combined with work in Primary Health Care (rural medicine, pediatrics, emergencies). Teaching in private and public health sciences (interim health area of ??the Junta de Castilla y León). Doctor of Medicine and Surgery "cum laude" from the Complutense University of Madridin 1992. President of the Spanish-Leonese Society of Acupuncturists, Homeopaths and Naturists, based at the Valladolid College of Physicians, from 1995 to 2014, with the performance of 14 scientific events (seminars, congresses, courses, conferences, etc. .) at the University of Valladolid, College of Physicians of Valladolid, Balneario Palacio de las Salinas in Medina del Campo (Valladolid), etc., with the participation of professors and professors from the University of Valladolid and foreign universities. Accredited courses in Primary Health Care, Gerontology, Advanced CPR, Electrocardiography, Digestive System, Pulmonology, etc. University of Zaragoza: Naturopathic Medicine (1996-98). University of Valladolid: University Specialist in Homeopathy (1994-96). University of Barcelona: Master in Phytotherapy (2007-2009). Spanish Association of Naturopathic Physicians (AEMN): several years on the board of directors. I have given more than 15 lectures to date, in the respective congresses, in various medical colleges and universities in Spain. Spanish Society of Homeopathic Medicine. European Society of Classical Naturopathic Medicine. Teaching official of the health area, specializing in health processes , of the Junta de Castilla y León, being the number one in the opposition. In 2010 he created the Institute of Integrative Medicine , as a teaching activity attached to the clinic, in Valladolid, in order to channel the teaching of Health Sciences. Doctor at the Palacio de Las Salinas Spa , in Medina del Campo (Valladolid) from 2007 to 2013. About 30 publications in national and foreign scientific journals, with research topics, history of medicine, prevention, therapy, medical hydrology, hydrotherapy, geotherapy, heliotherapy, mind-body medicine, environmental medicine, ecology and environment. Editor of Mednaturis, dictionary of concepts in naturopathic medicine, offered by the AEMN website for free. AEMN award in the 1995 edition for the work: "Influence of the medical act on the evolution and progression of diseases"

Abstract

Since the Human Microbiome project started in the first decade of this century, there have been many discoveries that have been revealed thanks to current technology. Not without reason is the intestinal microbiota (IM) considered an organ with digestive, metabolic, immunological, endocrine, psychoneurological, and purifying functions. These functions are achieved if there is eubiosis, with a good ratio between different species of bacteria and microbial diversity. Due to these properties, IM has been taken into account for years in drug development. Because commonly used drugs are potentiated, degraded or altered by IM, more time and financial resources should be allocated to expand the information on each active ingredient in this regard in order to increase the efficacy and safety of these drugs.